Sabal Trust’s Organon & Co OGN Stock Holding History

Sabal Trust’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-29,741	Closed	-$899K	–	151
2021 Q2	$899K	Buy	+29,741	New	+$979K	0.06%	77

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sabal Trust's OGN Position: Q3 2021 in Review

Sabal Trust sold out of Organon & Co (OGN) in Q3 2021, closing a stake of 29,741 shares — an estimated $899K sold.

Sabal Trust first reported a position in OGN in Q2 2021 and held it in 1 quarter. The position peaked at $899K in Q2 2021. 928 funds tracked by Wall St. Rank hold OGN as of Q3 2021.

Sabal Trust reported no remaining Organon & Co position as of Q3 2021 after selling out during the quarter.
Sabal Trust sold 29,741 Organon & Co shares in Q3 2021, an estimated $899K.
Sabal Trust first reported a position in Organon & Co in Q2 2021 and held it in 1 quarter.
Sabal Trust's Organon & Co position peaked at $899K in Q2 2021.
928 funds tracked by Wall St. Rank held Organon & Co as of Q3 2021.

Based on Sabal Trust's 13F filing for Q3 2021, filed 18 Oct 2021.